EUGLUCON Side Effects

6414615-2 | Anaemia, Hypoglycaemia
on Sep 28, 2009 Male patient from JAPAN , 80 years of age, was treated with Euglucon (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, hypoglycaemia. Euglucon dosage: . During the same period patient was treated with ARICEPT (View Aricept Review and Aricept Label ), ZYRTEC (View Zyrtec Review and Zyrtec Label ), GRAMALIL (View Gramalil Review and Gramalil Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6205573-4 | Acute Myocardial Infarction, Anorexia
Patient was taking Euglucon (View Usage). Patient had the following side effects: acute myocardial infarction, anorexia on May 22, 2009 from JAPAN Additional patient health information: Male patient , 66 years of age, weighting 165.3 lb, was diagnosed with large intestine carcinoma and. Euglucon dosage: . During the same period patient was treated with AVASTIN (Unk) (View Avastin Review and Avastin Label ), FLUOROURACIL (Unk) (View Fluorouracil Review and Fluorouracil Label ), ELPLAT (Unk) (View Elplat Review and Elplat Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ), CALCIUM LEVOFOLINATE (Unk) (View Calcium Levofolinate Review and Calcium Levofolinate Label ).

6199423-2 | Haemolytic Anaemia, Thrombocytopenia
Adverse event was reported on May 08, 2009 by a Female patient taking Euglucon (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: JAPAN , 77 years of age, After Euglucon was administered, patient had the following side effects: haemolytic anaemia, thrombocytopenia. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), ALOSITOL (View Alositol Review and Alositol Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), CARDENALIN (View Cardenalin Review and Cardenalin Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), NU LOTAN (View Nu-lotan Review and Nu-lotan Label ).

6157055-6 | Altered State Of Consciousness, Pneumonia Aspiration
on Apr 03, 2009 Female patient from JAPAN , 67 years of age, was diagnosed with diabetes mellitus and was treated with Euglucon (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, pneumonia aspiration. Euglucon dosage: . During the same period patient was treated with BASEN (View Basen Review and Basen Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), CARDENALIN (View Cardenalin Review and Cardenalin Label ), SELOKEN /00376902/ (View Seloken /00376902/ Review and Seloken /00376902/ Label ), NORVASC (View Norvasc Review and Norvasc Label ), BLOPRESS (View Blopress Review and Blopress Label ). Patient was hospitalized.


6132321-9 | Acute Myocardial Infarction, Anorexia
on Mar 17, 2009 Male patient from JAPAN , 66 years of age, was diagnosed with large intestine carcinoma and was treated with Euglucon (View Usage). Patient had the following side effects: acute myocardial infarction, anorexia. Euglucon dosage: . During the same period patient was treated with AVASTIN (Unk) (View Avastin Review and Avastin Label ), CALCIUM LEVOFOLINATE (Unk) (View Calcium Levofolinate Review and Calcium Levofolinate Label ), FLUOROURACIL (Unk) (View Fluorouracil Review and Fluorouracil Label ), ELPLAT (Unk) (View Elplat Review and Elplat Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

6047099-7 | Hypoglycaemia, Sopor
Patient was taking Euglucon (View Usage). After Euglucon was administered, patient had the following side effects: hypoglycaemia, sopor on Jan 15, 2009 from ITALY Additional patient health information: Male patient , 83 years of age, was diagnosed with diabetes mellitus, essential hypertension and. Euglucon dosage: . During the same period patient was treated with UNIPRIL /00885601/ (View Unipril /00885601/ Review and Unipril /00885601/ Label ).

5878269-6 | Hypoglycaemia, Loss Of Consciousness
Adverse event was reported on Aug 31, 2008 by a Male patient taking Euglucon (View Usage) (Dosage: ) . Location: ITALY , 77 years of age, Patient experienced the following unwanted or unexpected effects: hypoglycaemia, loss of consciousness. During the same period patient was treated with METFORAL (View Metforal Review and Metforal Label ), MADOPAR /00349201/ (View Madopar /00349201/ Review and Madopar /00349201/ Label ), TACHIPIRINA (View Tachipirina Review and Tachipirina Label ).

5864536-9 | Hypoglycaemic Coma
on Aug 25, 2008 Male patient from JAPAN , 74 years of age, was diagnosed with diabetes mellitus and was treated with Euglucon (View Usage). Patient had the following side effects: hypoglycaemic coma. Euglucon dosage: Dose: 2.5 Mg. During the same period patient was treated with LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ). Patient was hospitalized.

5821677-X | Cardiac Failure, Electrocardiogram Qt Prolonged, Syncope
on Jul 09, 2008 Female patient from JAPAN , 83 years of age, weighting 81.57 lb, was treated with Euglucon (View Usage). After Euglucon was administered, patient had the following side effects: cardiac failure, electrocardiogram qt prolonged, syncope. Euglucon dosage: . During the same period patient was treated with LANIRAPID (View Lanirapid Review and Lanirapid Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), ACETOHEXAMIDE (View Acetohexamide Review and Acetohexamide Label ), AMISALIN (View Amisalin Review and Amisalin Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5817320-6 | Cardiac Failure, Electrocardiogram Qt Prolonged, Syncope
Patient was taking Euglucon (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, electrocardiogram qt prolonged, syncope on Jul 09, 2008 from JAPAN Additional patient health information: Female patient , 83 years of age, weighting 81.57 lb, . Euglucon dosage: . During the same period patient was treated with LANIRAPID (View Lanirapid Review and Lanirapid Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), ACETOHEXAMIDE (View Acetohexamide Review and Acetohexamide Label ), AMISALIN (View Amisalin Review and Amisalin Label ), NIFEDIPINE (View Nifedipine Review and Nifedipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5807699-3 | Blood Glucose Decreased, Syncope
Adverse event was reported on Jul 03, 2008 by a Male patient taking Euglucon (View Usage) (Dosage: ) . Location: ITALY , 77 years of age, Patient had the following side effects: blood glucose decreased, syncope. During the same period patient was treated with METFORAL (View Metforal Review and Metforal Label ), MADOPAR /00349201/ (View Madopar /00349201/ Review and Madopar /00349201/ Label ), TACHIPIRINA (View Tachipirina Review and Tachipirina Label ).

5777299-2 | Cerebral Infarction
on Jun 03, 2008 Male patient from JAPAN , 53 years of age, was treated with Euglucon (View Usage). After Euglucon was administered, patient had the following side effects: cerebral infarction. Euglucon dosage: .

5764889-6 | Cerebral Infarction
on May 24, 2008 Male patient from JAPAN , 53 years of age, was treated with Euglucon (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral infarction. Euglucon dosage: .

5716209-0 | Anaemia, Myelodysplastic Syndrome, Platelet Count Decreased, White Blood Cell Count Decreased
Patient was taking Euglucon (View Usage). Patient had the following side effects: anaemia, myelodysplastic syndrome, platelet count decreased, white blood cell count decreased on Apr 11, 2008 from JAPAN Additional patient health information: Male patient , 81 years of age, . Euglucon dosage: . Patient was hospitalized.

5705925-2 | Anaemia, Myelodysplastic Syndrome, Platelet Count Decreased, White Blood Cell Count Decreased
Adverse event was reported on Apr 03, 2008 by a Male patient taking Euglucon (View Usage) (Dosage: ) . Location: JAPAN , 81 years of age, After Euglucon was administered, patient had the following side effects: anaemia, myelodysplastic syndrome, platelet count decreased, white blood cell count decreased. Patient was hospitalized.

5334572-X | Accidental Exposure, Hypoglycaemia
on May 21, 2007 Male patient from JAPAN , 70 years of age, was treated with Euglucon (View Usage). Patient experienced the following unwanted or unexpected effects: accidental exposure, hypoglycaemia. Euglucon dosage: . During the same period patient was treated with GLUCOSE (Dose: Unk) (View Glucose Review and Glucose Label ).

5291792-0 | Hallucination
on Apr 04, 2007 Female patient from JAPAN , 77 years of age, was treated with Euglucon (View Usage). Patient had the following side effects: hallucination. Euglucon dosage: Dose: Unk. During the same period patient was treated with TAMIFLU (View Tamiflu Review and Tamiflu Label ), NORVASC (Dose: Unk) (View Norvasc Review and Norvasc Label ), DIOVAN (Dose: Unk) (View Diovan Review and Diovan Label ), HOKUNALIN (View Hokunalin Review and Hokunalin Label ), FAMOTIDINE (Dose: Unk) (View Famotidine Review and Famotidine Label ), THEO DUR (Dose: Unk) (View Theo-dur Review and Theo-dur Label ), FLUTICASONE PROPIONATE (Dose: Unk) (View Fluticasone Propionate Review and Fluticasone Propionate Label ), ACTOS (Dose: Unk) (View Actos Review and Actos Label ).

5220737-4 | Convulsion, Hypoglycaemic Coma
Patient was taking Euglucon (View Usage). After Euglucon was administered, patient had the following side effects: convulsion, hypoglycaemic coma on Jan 22, 2007 from JAPAN Additional patient health information: Female patient , 84 years of age, was diagnosed with diabetes mellitus and. Euglucon dosage: . Patient was hospitalized.

5159705-X | Hypoglycaemia, Hypoglycaemic Coma
Adverse event was reported on Sep 21, 2006 by a Female patient taking Euglucon (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: JAPAN , 85 years of age, Patient experienced the following unwanted or unexpected effects: hypoglycaemia, hypoglycaemic coma. During the same period patient was treated with CALBLOCK (View Calblock Review and Calblock Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5138190-8 | Cardio-respiratory Arrest, Hypoglycaemic Coma, Pulmonary Embolism
on Oct 18, 2006 Female patient from JAPAN , 81 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Euglucon (View Usage). Patient had the following side effects: cardio-respiratory arrest, hypoglycaemic coma, pulmonary embolism (What is pulmonary embolism?). Euglucon dosage: . During the same period patient was treated with PIOGLITAZONE HCL (View Pioglitazone Hcl Review and Pioglitazone Hcl Label ). Patient was hospitalized.

5132925-6 | Hypoglycaemia, Muscle Spasms, Muscle Twitching, Nausea
on Sep 21, 2006 Female patient from JAPAN , 85 years of age, was diagnosed with diabetes mellitus and was treated with Euglucon (View Usage). After Euglucon was administered, patient had the following side effects: hypoglycaemia, muscle spasms, muscle twitching, nausea (What is nausea?). Euglucon dosage: . During the same period patient was treated with CALBLOCK (View Calblock Review and Calblock Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), VOGLIBOSE (View Voglibose Review and Voglibose Label ), TERAZOSIN HCL (View Terazosin Hcl Review and Terazosin Hcl Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5115225-X | Hypoglycaemia, Hypoglycaemic Coma, Loss Of Consciousness
Patient was taking Euglucon (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia, hypoglycaemic coma, loss of consciousness on Sep 21, 2006 from JAPAN Additional patient health information: Female patient , 85 years of age, . Euglucon dosage: . Patient was hospitalized.

5112578-3 | Acidosis, Hypoglycaemia
Adverse event was reported on Sep 19, 2006 by a Female patient taking Euglucon (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: , 65 years of age, Patient had the following side effects: acidosis, hypoglycaemia. During the same period patient was treated with DIANBEN (View Dianben Review and Dianben Label ), DONEKA PLUS (View Doneka Plus Review and Doneka Plus Label ), ADIRO (View Adiro Review and Adiro Label ), EMCONCOR (View Emconcor Review and Emconcor Label ), PANTOK (View Pantok Review and Pantok Label ). Patient was hospitalized.

5071266-2 | Coordination Abnormal, Tremor
on Jun 16, 2006 Male patient from GERMANY , 91 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Euglucon (View Usage). After Euglucon was administered, patient had the following side effects: coordination abnormal, tremor. Euglucon dosage: . During the same period patient was treated with ACTOS (Dose: Not Reported) (View Actos Review and Actos Label ). Patient was hospitalized.

5043073-8 | Blood Pressure Diastolic Increased, Glycosylated Haemoglobin Increased, Hypoglycaemic Coma, Lactic Acidosis, Overdose, Renal Failure, Respiratory Rate Increased
on Jun 14, 2006 Male patient from JAPAN , 67 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with Euglucon (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure diastolic increased, glycosylated haemoglobin increased, hypoglycaemic coma, lactic acidosis, overdose, renal failure, respiratory rate increased. Euglucon dosage: . During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

5015568-4 | Diarrhoea, Hypoglycaemic Encephalopathy, Nasopharyngitis
Patient was taking Euglucon (View Usage). Patient had the following side effects: diarrhoea, hypoglycaemic encephalopathy, nasopharyngitis on May 17, 2006 from JAPAN Additional patient health information: Female patient , 78 years of age, was diagnosed with diabetes mellitus and. Euglucon dosage: . Patient was hospitalized.

4865984-6 | Alveolitis Allergic, Aplastic Anaemia, Lung Disorder, Oedema Peripheral, Pleural Effusion, Rales
Adverse event was reported on Dec 06, 2005 by a Female patient taking Euglucon (View Usage) (Dosage: ) was diagnosed with diabetes mellitus non-insulin-dependent and. Location: JAPAN , 84 years of age, After Euglucon was administered, patient had the following side effects: alveolitis allergic, aplastic anaemia, lung disorder, oedema peripheral, pleural effusion, rales. During the same period patient was treated with BASEN (View Basen Review and Basen Label ), ACTOS (View Actos Review and Actos Label ). Patient was hospitalized.

4853683-6 | Aplastic Anaemia, Lung Disorder
on Dec 06, 2005 Female patient from JAPAN , 84 years of age, was diagnosed with diabetes mellitus and was treated with Euglucon (View Usage). Patient experienced the following unwanted or unexpected effects: aplastic anaemia, lung disorder. Euglucon dosage: .

4816506-7 | Leg Amputation, Skin Ulcer
on Oct 25, 2005 Male patient from COLOMBIA , 79 years of age, was diagnosed with diabetes mellitus and was treated with Euglucon (View Usage). Patient had the following side effects: leg amputation, skin ulcer. Euglucon dosage: . During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), TEGRETOL (View Tegretol Review and Tegretol Label ), HUMULIN (View Humulin Review and Humulin Label ). Patient was hospitalized.

4791301-6 | Diabetic Ketoacidosis, Metabolic Acidosis
Patient was taking Euglucon (View Usage). After Euglucon was administered, patient had the following side effects: diabetic ketoacidosis, metabolic acidosis on Sep 02, 2005 from GERMANY Additional patient health information: Female patient , 68 years of age, was diagnosed with hyperglycaemia, breast cancer (What is breast cancer?) and. Euglucon dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), VELCADE (Dose: 4 X Per 3 Week) (View Velcade Review and Velcade Label ), AROMASIN (View Aromasin Review and Aromasin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TRAMADOL (View Tramadol Review and Tramadol Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

4764994-7 | Blood Glucose Increased, Metabolic Acidosis
Adverse event was reported on Sep 02, 2005 by a Female patient taking Euglucon (View Usage) (Dosage: ) was diagnosed with hyperglycaemia, breast cancer (What is breast cancer?) and. Location: GERMANY , 68 years of age, Patient experienced the following unwanted or unexpected effects: blood glucose increased, metabolic acidosis. During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), VELCADE (Dose: 4 X Per 3 Week) (View Velcade Review and Velcade Label ), AROMASIN (View Aromasin Review and Aromasin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ). Patient was hospitalized.

4702163-7 | Idiopathic Thrombocytopenic Purpura
on Jun 13, 2005 Female patient from , 75 years of age, was diagnosed with blood glucose decreased, hyperlipidaemia and was treated with Euglucon (View Usage). Patient had the following side effects: idiopathic thrombocytopenic purpura. Euglucon dosage: Dose: 1.25 Mg 1 X Per Day. During the same period patient was treated with MEVALOTIN (View Mevalotin Review and Mevalotin Label ), LONGES (View Longes Review and Longes Label ), FRANDOL (View Frandol Review and Frandol Label ), BLOPRESS (View Blopress Review and Blopress Label ). Patient was hospitalized.

4673866-8 | Hypoglycaemia, Loss Of Consciousness
on May 10, 2005 Female patient from , 82 years of age, weighting 114.6 lb, was diagnosed with diabetes mellitus, hyperlipidaemia, hypertension, depression (What is depression?) and was treated with Euglucon (View Usage). After Euglucon was administered, patient had the following side effects: hypoglycaemia, loss of consciousness. Euglucon dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), COZAAR (View Cozaar Review and Cozaar Label ), NORVASC (View Norvasc Review and Norvasc Label ), SULPIRIDE (View Sulpiride Review and Sulpiride Label ). Patient was hospitalized.

4666137-7 | Hypoglycaemia
Patient was taking Euglucon (View Usage). Patient experienced the following unwanted or unexpected effects: hypoglycaemia on May 10, 2005 from Additional patient health information: Female patient , 82 years of age, was diagnosed with diabetes mellitus, hyperlipidaemia, hypertension, depression (What is depression?) and. Euglucon dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), COZAAR (View Cozaar Review and Cozaar Label ), NORVASC (View Norvasc Review and Norvasc Label ), SULPIRIDE (View Sulpiride Review and Sulpiride Label ).

4625855-7 | Cerebellar Infarction, Dizziness, Extrasystoles, Nausea
Adverse event was reported on Mar 22, 2005 by a Female patient taking Euglucon (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: , 72 years of age, Patient had the following side effects: cerebellar infarction, dizziness (What is dizziness?), extrasystoles, nausea (What is nausea?). During the same period patient was treated with DIANBEN (View Dianben Review and Dianben Label ), SEGURIL (Dose: Unk) (View Seguril Review and Seguril Label ), COZAAR (Dose: Unk) (View Cozaar Review and Cozaar Label ), SINTROM (Dose: Unk) (View Sintrom Review and Sintrom Label ), LEVOTHROID (Dose: Unk) (View Levothroid Review and Levothroid Label ). Patient was hospitalized.

4586813-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Biliary Tract Disorder, Erythema, Feeling Hot, Hepatic Function Abnormal, Hypersensitivity, Interstitial Lung Disease, Liver Disorder
on Dec 07, 2004 Male patient from , 54 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, hepatitis c (What is hepatitis c?), insomnia and was treated with Euglucon (View Usage). After Euglucon was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, biliary tract disorder, erythema, feeling hot, hepatic function abnormal, hypersensitivity, interstitial lung disease, liver disorder. Euglucon dosage: . During the same period patient was treated with URSO 250 (View Urso 250 Review and Urso 250 Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ), BASEN (View Basen Review and Basen Label ), NORVASC (Dose: Unk) (View Norvasc Review and Norvasc Label ), CONAN (Dose: Unk) (View Conan Review and Conan Label ), DIOVAN (Dose: Unk) (View Diovan Review and Diovan Label ).

4543826-6 | Cholangitis Acute
on Nov 29, 2004 Male patient from , weighting 149.9 lb, was diagnosed with diabetes mellitus, pancreatic insufficiency, hypertension, hyperlipidaemia, hypersensitivity and was treated with Euglucon (View Usage). Patient experienced the following unwanted or unexpected effects: cholangitis acute. Euglucon dosage: Daily Dose: 2.5 Milligram(s). During the same period patient was treated with CREON (Daily Dose: 9 Gram(s)) (View Creon Review and Creon Label ), LONGES (Daily Dose: 20 Milligram(s)) (View Longes Review and Longes Label ), MEVALOTIN (Daily Dose: 20 Milligram(s)) (View Mevalotin Review and Mevalotin Label ), ALESION (Daily Dose: 20 Milligram(s)) (View Alesion Review and Alesion Label ). Patient was hospitalized.

4543210-5 | Interstitial Lung Disease
Patient was taking Euglucon (View Usage). Patient had the following side effects: interstitial lung disease on Dec 07, 2004 from Additional patient health information: Male patient , 54 years of age, was diagnosed with diabetes mellitus non-insulin-dependent, hepatitis c (What is hepatitis c?), insomnia and. Euglucon dosage: . During the same period patient was treated with URSO 250 (View Urso 250 Review and Urso 250 Label ), ROHYPNOL (View Rohypnol Review and Rohypnol Label ), BASEN (View Basen Review and Basen Label ), NORVASC (Dose: Unk) (View Norvasc Review and Norvasc Label ), CONAN (Dose: Unk) (View Conan Review and Conan Label ), DIOVAN (Dose: Unk) (View Diovan Review and Diovan Label ).